Prophylactic treatment with 17-alpha-hydroxyprogesterone caproate (17Pc) in twin pregnancy does not reduce neonatal morbidity or prolong gestation, according to a study published in the March issue of the American Journal of Obstetrics & Gynecology.
THURSDAY, March 17 (HealthDay News) -- Prophylactic treatment with 17-alpha-hydroxyprogesterone caproate (17Pc) in twin pregnancy does not reduce neonatal morbidity or prolong gestation, according to a study published in the March issue of the American Journal of Obstetrics & Gynecology.
C. Andrew Combs, M.D., Ph.D., from the Obstetrix Medical Group in Sunrise, Fla., and colleagues assessed whether prophylactic treatment with 17Pc reduced neonatal morbidity by prolonging pregnancy in 240 mothers carrying dichorionic-diamniotic twins. Participants were randomly divided into two groups: 160 received weekly 17Pc injections of 250 mg and 80 received placebo starting between weeks 16 and 24 of pregnancy and continuing until 34 weeks. Composite neonatal morbidity and gestational age were the main outcomes of the study.
The investigators found that the frequency of composite neonatal morbidity was similar in the 17Pc and placebo groups (14 and 12 percent, respectively). There was no significant difference in the mean gestational age at delivery between the two groups, but there was a significant difference in the median gestational age, with the duration in the placebo group three days longer. No perinatal deaths were reported in the 17Pc group but the placebo group had three deaths.
"Our findings add to a growing body of evidence that progestins are not effective for prevention of prematurity in multiple gestations," the authors write.
Related Contenc
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Study shows a healthy prenatal diet could be upstream obesity prevention strategy
December 26th 2024"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ranges."
Read More
Early pregnancy cannabis use high in states with recreational legalization
November 11th 2024A population-based time-series analysis California before, during and after legalization show a rising trend in women using cannabis while pregnancy especially when the state has legalized the drug.
Read More